ALS risk factors

Posted on Saturday, May 1, 2010 - 11:54, By: ALSN Staff
Cytokinetics seeks participants for CK-2017357 study Cytokinetics, a South San Francisco biotechnology company, is seeking participants with ALS for a trial of its experimental compound CK-2017357.
Posted on Friday, January 1, 2010 - 10:48, By: ALSN Staff
The items in this article address research in ALS as of December 31, 2009, on these topics: Gulf War connection, smoking, serum lipids, arimoclomol study, microRNA 206 potential. Why wait for the next ALS Newsmagazine? Receive monthly e-mail summaries of breaking research news directly in your...

The year in research

Posted on Thursday, May 1, 2008 - 17:00, By: Margaret Wahl
The road to ALS treatment development has been long and hard. But MDA, along with the National Institutes of Health (NIH) and pharmaceutical companies, is finding there are more frequent signposts. Among the most interesting developments of this year is the finding in a 44-person study in Italy...